Green Thumb Industries (GTBIF) Change in Accured Expenses (2019 - 2026)
Green Thumb Industries (GTBIF) posted Change in Accured Expenses of -$4.1 million for Q1 2026, down 133.38% on a QoQ basis from $12.2 million in Q4 2025, and down 237.58% year-over-year from $3.0 million in Q1 2025.
Green Thumb Industries (GTBIF) Change in Accured Expenses (2019 - 2026) Analysis & Trends
Green Thumb Industries' Change in Accured Expenses history runs 8 years deep, the most recent figure standing at -$4.1 million for Q1 2026.
- Quarterly Change in Accured Expenses fell 237.58% year-over-year to -$4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (down 56.77% YoY) and the FY2025 annual result came in at $12.1 million, down 26.52% from the prior year.
- Change in Accured Expenses was -$4.1 million for Q1 2026 at Green Thumb Industries, down from $12.2 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $19.7 million in Q3 2024 and bottomed at -$20.9 million in Q2 2025.
- A 5-year average of $1.8 million and a median of $687000.0 in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses slumped 556.83% — and 2024, when it soared 2762.88%.
- Green Thumb Industries' Change in Accured Expenses stood at $6.4 million in 2022, then plunged by 116.84% to -$1.1 million in 2023, then grew by 6.56% to -$1.0 million in 2024, then jumped by 1307.21% to $12.2 million in 2025, then plunged by 133.38% to -$4.1 million in 2026.
- Business Quant data shows GTBIF's Change in Accured Expenses at -$4.1 million in Q1 2026, $12.2 million in Q4 2025, and $17.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | -144.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -234.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -12.70 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -14.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | -4.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.08 Mn |
| Mar 31, 2026 | -4.08 Mn |
| Dec 31, 2025 | 12.22 Mn |
| Dec 31, 2025 | 12.22 Mn |
| Sep 30, 2025 | 17.80 Mn |
| Sep 30, 2025 | 17.80 Mn |
| Jun 30, 2025 | -20.87 Mn |
| Jun 30, 2025 | -20.87 Mn |
| Mar 31, 2025 | 2.96 Mn |
| Mar 31, 2025 | 2.96 Mn |
| Dec 31, 2024 | -1.01 Mn |
| Dec 31, 2024 | -1.01 Mn |
| Sep 30, 2024 | 19.67 Mn |
| Sep 30, 2024 | 19.67 Mn |
| Jun 30, 2024 | -9.88 Mn |
| Jun 30, 2024 | -9.88 Mn |
| Mar 31, 2024 | 7.71 Mn |
| Mar 31, 2024 | 7.71 Mn |
| Dec 31, 2023 | -1.08 Mn |
| Dec 31, 2023 | -1.08 Mn |